-
Recursion Pharmaceuticals (NASDAQ:RXRX) Receives "Buy" Rating from Needham & Company LLC
Source: Buzz FX / 11 Dec 2024 09:57:10 America/New_York
Recursion Pharmaceuticals (NASDAQ:RXRX) Receives "Buy" Rating from Needham & Company LLC Written by MarketBeat December 11, 2024 Share Link copied to clipboard. Recursion Pharmaceuticals ( NASDAQ:RXRX - Get Free Report ) 's stock had its "b
Read more...